| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/23/2003 | US20030017499 Method for detecting transcription factor-protein interactions |
| 01/23/2003 | US20030017498 Nucleotide sequences coding polypeptides for use as tools in pharmacology, diagnostics, biosensors and bioreactors |
| 01/23/2003 | US20030017497 Peptide mimotopes of carbohydrate antigens |
| 01/23/2003 | US20030017495 Enterococcus faecalis polynucleotides and polypeptides |
| 01/23/2003 | US20030017494 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030017493 Diagnosing multiple sclerosis and chronic fatigue syndrome; obtain sample, monitor p53 expression factor, evaluate for multiple sclerosis and chronic fatigue syndrome |
| 01/23/2003 | US20030017492 Methods for diagnosis and treatment of chronic immune diseases |
| 01/23/2003 | US20030017489 PRMTs as modifiers of the p53 pathway and methods of use |
| 01/23/2003 | US20030017488 Method for testing a therapeutic or preventive agent for hyperlipidemia |
| 01/23/2003 | US20030017486 Method for preparation of RNA probe, method for detecting targeted nucleic acid, and kit for preparation of RNA probe |
| 01/23/2003 | US20030017485 Detection of chemoattractant receptor antagonist; obtain cell, incubate with antagonist, expose to ligand, monitor cell migration, adjust in cell migration indicates antagonist |
| 01/23/2003 | US20030017482 PCR method |
| 01/23/2003 | US20030017481 Methods for classifying samples and ascertaining previously unknown classes |
| 01/23/2003 | US20030017479 Methods for the detection, treatment, and prevention of neurodegeneration |
| 01/23/2003 | US20030017478 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2003 | US20030017476 Nucleotide sequence coding polypeptide for use in the treatment and diagnosis of nervous system disorders |
| 01/23/2003 | US20030017474 Methods for identifying the evolutionarily conserved sequences |
| 01/23/2003 | US20030017466 Diagnosi and treatment of cancer; obtain tissue sample, monitor gene expression in sample, monitor methylation in sample, compare to control, evaluate for cancer |
| 01/23/2003 | US20030017465 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
| 01/23/2003 | US20030017464 Latex based adsorbent chip |
| 01/23/2003 | US20030017463 Nucleotide sequence coding polypeptide for use in the treatment of heart, cancer and skin disorders |
| 01/23/2003 | US20030017456 Diagnosis and treatment and related preparations |
| 01/23/2003 | US20030017450 Detection of viral nucleotide sequences in sample; obtain sample, denature, incubate with pimers, hybridize, amplify, expose to probe, detect signal presence indicates viral nucleotide sequences |
| 01/23/2003 | US20030017447 Detection of preferential antibodies on solid support; obtain sample, incubate with solid support, expose to antibodies, detect signal on support, presence of signal indicates antibody |
| 01/23/2003 | US20030017445 Patient classification |
| 01/23/2003 | US20030017250 Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected |
| 01/23/2003 | US20030017160 Human checkpoint kinase, hCDS1, compositions and methods |
| 01/23/2003 | US20030017158 Selectively marking the mitochondria of the cancer cells, by delivering to the epithelium a cationic supravital mitochondrial marking agent. |
| 01/23/2003 | US20030017157 Endothelial cell expression patterns |
| 01/23/2003 | US20030017156 Immunogenic polypeptide |
| 01/23/2003 | US20030017155 Treating a condition characterized by activation of the inflammatory cytokine cascade |
| 01/23/2003 | US20030017147 Novel alpha-2-antiplasmin- binding molecules and treatment for pulmonary embolism, myocardial infarction, thrombosis or stroke in a patient |
| 01/23/2003 | US20030017143 Reduction of risk of rejection of allografts and xenografts and autoimmune diseases using the human suppressor CD8+CD28- T cells |
| 01/23/2003 | US20030017141 Treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 01/23/2003 | US20030017077 Sample clean-up apparatus for mass spectrometry |
| 01/23/2003 | US20030017075 In which the microscope slide are conducted in the same apparatus, wherein the microscope slides do not need to by physically removed from one apparatus to another. Each treatment step occurs within the same reaction compartment. |
| 01/23/2003 | US20030016897 Target analyte sensors utilizing microspheres |
| 01/23/2003 | US20030016009 Apparatus and method for resistivity measurement of concrete |
| 01/23/2003 | US20030016002 Differential conductivity hemodynamic monitor |
| 01/23/2003 | US20030015474 Interpolar magnets are positioned to progressively rotate towards the orientation of the four polar magnets to create an even flux within a liquid sample and cause the radial movement of magnetized particles toward the inner wall |
| 01/23/2003 | US20030015428 Dielectrically-engineered microparticles |
| 01/23/2003 | US20030015426 For conducting isoelectric focusing using immobilized pH gradient (IPG) strips; obviates the use of an occlusive oil layer, and allows vertical orientation; by hydratingly lodging a hydratable separation medium within an enclosure |
| 01/23/2003 | US20030015208 Methods to diagnose treat and prevent bone loss |
| 01/23/2003 | US20030015131 Silicon Wafer, Method for Determining Production Conditions of Silicon Single Crystal and Method for Producing Silicon Wafer |
| 01/23/2003 | US20030015027 Automatic transmission fluid characteristic monitoring system employed for repair/maintenance and during operation of a land motor vehicle |
| 01/23/2003 | US20030015019 Method and apparatus for concentrating samples for analysis |
| 01/23/2003 | DE20215270U1 Device for immunological detection of an antigen or antibody, useful e.g. for diagnosis of Lyme disease, comprises several connected membranes |
| 01/23/2003 | DE10158077C1 Determining density of measuring gas, especially fuel gas, involves passing measuring gas and reference gas through apertures and mixing together |
| 01/23/2003 | DE10139298C1 Process for recognizing a boundary surface adhesion during a molding process between a glass body and electrically conducting tools comprises using an electromotive force value between the tools to indicate the boundary surface adhesion |
| 01/23/2003 | CA2821544A1 Use of follistatin for the treatment of pulmonary fibrosis and fibrosis associated with inflammatory bowel disease |
| 01/23/2003 | CA2460642A1 Diagnosis and treatment of diseases associated with altered expression of hipk1 |
| 01/23/2003 | CA2457408A1 System and method for aqueous solubility prediction |
| 01/23/2003 | CA2454192A1 Method and device for determination of and imaging of an environment subjectively taken to be real by a person |
| 01/23/2003 | CA2454135A1 Gpcs as modifiers of the irrtk and p21 pathways and methods of use |
| 01/23/2003 | CA2453871A1 Hadhs molecules as modifiers of the p21 pathway and methods of use |
| 01/23/2003 | CA2453764A1 System and method for storing mass spectrometry data |
| 01/23/2003 | CA2453725A1 System and method of determining proteomic differences |
| 01/23/2003 | CA2453574A1 Transgenic plants expressing cobalamin binding proteins |
| 01/23/2003 | CA2453554A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 01/23/2003 | CA2453546A1 System and method for differential protein expression and a diagnostic biomarker discovery system and method using same |
| 01/23/2003 | CA2453538A1 Method for determination of denatured lipoprotein, reagent for determination of denatured lipoprotein, method for detection of cardiovascular disease, and reagent for detection ofcardiovascular disease |
| 01/23/2003 | CA2453534A1 Method for obtaining a titrated preparation of algae and resulting titrated preparations |
| 01/23/2003 | CA2453524A1 Methods and devices based upon a novel form of nucleic acid duplex on a surface |
| 01/23/2003 | CA2453496A1 Survivin interacting protein tpr1 |
| 01/23/2003 | CA2453494A1 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | CA2453489A1 Electrical field stimulation of eukaryotic cells |
| 01/23/2003 | CA2453470A1 Use of follistatin for the treatment of hepatic fibrogenesis |
| 01/23/2003 | CA2453399A1 Combinations for the treatment of inflammatory disorders |
| 01/23/2003 | CA2453360A1 Internal calibration standards for electrophoretic analyses |
| 01/23/2003 | CA2453227A1 Method for calibrating a mass spectrometer |
| 01/23/2003 | CA2453222A1 Method and apparatus for identifying components of a system with a response characteristic |
| 01/23/2003 | CA2453175A1 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | CA2453161A1 Lymphatic endothelial cells materials and methods |
| 01/23/2003 | CA2453141A1 Afinity biosensor for monitoring of biological process |
| 01/23/2003 | CA2452867A1 Allelic variants of gpr50 |
| 01/23/2003 | CA2452593A1 Triple polypeptide complexes |
| 01/23/2003 | CA2452337A1 Use of specific t2r taste receptors to identify compounds that block bitter taste |
| 01/23/2003 | CA2394765A1 Method and apparatus for estimating solvation energies of membrane bound molecules |
| 01/23/2003 | CA2353687A1 Assays for detecting and quantifying contaminants and compositions for use in same |
| 01/22/2003 | EP1278275A2 Modular analysis system |
| 01/22/2003 | EP1278065A1 Method of detecting streptococcus sobrinus and antibody therefor |
| 01/22/2003 | EP1278064A1 High-density microelectrode arrangement |
| 01/22/2003 | EP1278063A1 Imobilization of biomolecules |
| 01/22/2003 | EP1278062A2 System and method of taste recognition |
| 01/22/2003 | EP1278061A1 Chemical sensors from nanoparticle/dendrimer composite materials |
| 01/22/2003 | EP1277843A2 Novel human genes and gene expression products related to colon cancer |
| 01/22/2003 | EP1277842A2 Method for quantifying nucleic acid by cell counting |
| 01/22/2003 | EP1277837A2 Epididymis-specific DNA sequences and their use |
| 01/22/2003 | EP1277836A1 Modulation of the IAPs and NAIP for the treatment of proliferative diseases |
| 01/22/2003 | EP1277764A2 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/22/2003 | EP1277762A2 Low allergenic protein variants |
| 01/22/2003 | EP1277760A1 Method of searching for arteriosclerosis inhibitors and shrinkers |
| 01/22/2003 | EP1277476A1 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator |
| 01/22/2003 | EP1277438A1 System for point of care diagnosis and/or analysis |
| 01/22/2003 | EP1277160A1 Method and apparatus for detecting outliers in biological/pharmaceutical screening experiments |
| 01/22/2003 | EP1277103A2 System, method, and computer software product for linked window interfaces |
| 01/22/2003 | EP1277057A2 Screening method for compounds |
| 01/22/2003 | EP1277056A2 Use of ink-jet printing to produce diffraction-based biosensors |
| 01/22/2003 | EP1277055A1 Biochip for the archiving and medical laboratory analysis of biological sample material |
| 01/22/2003 | EP1277054A1 Electrochemical sensing |